New Model Approaches for Drug Screening and Discovery

Pre-clinical and non-clinical drug testing rely heavily on whether the models used can accurately reca­pitulate complex biological processes. Historically, scientists have turned to animal models, which are time-consuming to generate and maintain. Additionally, there is always a disconnect between the models and human physiology. Thus, there is a recent push from regulatory agencies to develop and use advanced in vitro models such as organoids and spheroids for drug screening and testing.

Download this compendium to learn how these new model technologies are reshaping drug screening and discovery.

Here is a look at what’s inside

• eBook: High Throughput Screening Models Ramp Up Lead Discovery
• Infographic: Organoids, the New Frontier
• Poster: Fully Automated Development of iPSC-Derived 3D Neural Organoids
• Application Note: Screening 3D Spheroids Using a Next-Generation Imager